Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in biomarkers research, from development and diagnostics to precision medicine

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Biomarker Technologies

MILLIPLEX Human Cytokine Panel: A Lot to Lot Consistency of Cytokine Measurement

Read More
Biomarker Technologies

Optimer - Accelerating Your Journey to the Clinic

Read More
Biomarker Technologies

Optimer - Drug Conjugates

Read More
Biomarker Technologies

Optimer - Enabled Small Molecule Detection and Analysis

Read More
Biomarker Technologies

Optimer Diagnostic Reagent COVID-19 Datapack

Read More
Biomarker Technologies

Supelco - BIOshell Peptide Mapping Trastuzumab UHPLC-MS

Read More
Biomarker Technologies

Supelco - Supel Carbon N-Glycan Human IgG

Read More
Biomarker Technologies

The Optimer Discovery Platform

Read More
Biomarker Technologies

Whole Exome Sequencing (WES) Data Generation Service

Read More
Biomarkers for Clinical Development

Surrogate Biomarkers in NASH and Liver Cirrhosis: Qualifying for Clinical Trial Validation and Legislative Success

Highly involved treatment scenarios and prognostics are required to properly assess best-practice approaches for investigating issues posed by NASH and liver cirrhosis. Surrogate biomarkers present a less invasive approach to assessing these outcomes.
Read More
Diagnostics

Emergency Use Authorization Issued by FDA for Mpox Virus DNA Test

EUAs exist under FDA regulation to improve the availability of medical countermeasures, such as vaccines and diagnostic tests, during public health emergencies. With future pandemics a tangible possibility, further EUAs for other PCR tests and vaccines are all but certain.
Read More
Genomic Markers & Precision Medicine

Clinical Biomarker Trends to Watch in 2023

The identification of novel clinical biomarkers is set to continue, with further research and investment in fields such as next-gen sequencing and miRNA targeting.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biomarkers